Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Haag

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 16, 2020
Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain AxisMelinda A Engevik, Berkley Luck, Chonnikant Visuthranukul, et al.
Iscience|April 1, 2022
Mathematical models to study the biology of pathogens and the infectious diseases they causeJoao B Xavier, Jonathan M Monk, Saugat Poudel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study GroupRalf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, et al.
Nature Genetics|October 24, 2024
Systematic perturbation screens identify regulators of inflammatory macrophage states and a role for TNF mRNA m6A modificationSimone M Haag, Shiqi Xie, Celine Eidenschenk, et al.
Molecular Cancer|January 10, 2024
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based thresholdTim Schmäche, Juliane Fohgrub, Anna Klimova, et al.
ESMO Open|January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer studyG Ku, G M Haag, H Park, et al.
Neuron|March 27, 2026
Microglia-mediated protection against Alzheimer's disease pathology and detrimental effects in white matter revealed by Ptpn6 deletionAinhoa Etxeberria, Seung-Hye Lee, Julia A Kuhn, et al.
Nature Cancer|July 15, 2022
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapyThomas Walle, Sunanjay Bajaj, Joscha A Kraske, et al.
Nature Cancer|June 17, 2022
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapyThomas Walle, Sunanjay Bajaj, Joscha A Kraske, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
ESMO Gastrointestinal Oncology|February 6, 2026
TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patientsB C Köhler, G M Haag, L Le Cornet, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 16, 2020
Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain AxisMelinda A Engevik, Berkley Luck, Chonnikant Visuthranukul, et al.
Iscience|April 1, 2022
Mathematical models to study the biology of pathogens and the infectious diseases they causeJoao B Xavier, Jonathan M Monk, Saugat Poudel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study GroupRalf-Dieter Hofheinz, Kirsten Merx, Georg M Haag, et al.
Nature Genetics|October 24, 2024
Systematic perturbation screens identify regulators of inflammatory macrophage states and a role for TNF mRNA m6A modificationSimone M Haag, Shiqi Xie, Celine Eidenschenk, et al.
Molecular Cancer|January 10, 2024
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based thresholdTim Schmäche, Juliane Fohgrub, Anna Klimova, et al.
ESMO Open|January 11, 2025
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer studyG Ku, G M Haag, H Park, et al.
Neuron|March 27, 2026
Microglia-mediated protection against Alzheimer's disease pathology and detrimental effects in white matter revealed by Ptpn6 deletionAinhoa Etxeberria, Seung-Hye Lee, Julia A Kuhn, et al.
Nature Cancer|July 15, 2022
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapyThomas Walle, Sunanjay Bajaj, Joscha A Kraske, et al.
Nature Cancer|June 17, 2022
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapyThomas Walle, Sunanjay Bajaj, Joscha A Kraske, et al.
Pageof 28